About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Bcl2l11
BCL2 like 11
MGI:1197519
102 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
\Atmintm1.1Jhh/\Atmintm1.1Jhh
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Cd79atm1(cre)Reth/\Cd79a+
\Tg(IghMyc)22Bri/0
B6.Cg-Bcl2l11tm1.1Ast Cd79atm1(Cre)Reth Atmintm1.1Jhh Tg(IghMyc)22Bri 		increased lymphoma incidence J:230105
\Atmintm1.2Jhh/\Atmintm1.2Jhh
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Cd79atm1(cre)Reth/\Cd79a+
involves: 129S1/Sv * BALB/c * C57BL/6 		enlarged spleen J:191832
normal immune system phenotype J:191832
increased B cell number J:191832
increased immature B cell number J:191832
increased pre-B cell number J:191832
increased spleen weight J:191832
\Baxtm1Sjk/\Baxtm1Sjk
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
B6.129-Bcl2l11tm1.1Ast Baxtm1Sjk 		abnormal seminiferous tubule epithelium morphology J:103605
arrest of male meiosis J:103605
azoospermia J:103605
male infertility J:103605
small seminiferous tubules J:103605
\Bcl2tm1Dlo/\Bcl2tm1Dlo
\Bcl2l11tm1.1Ast/\Bcl2l11+
B6.129-Bcl2tm1Dlo Bcl2l11tm1.1Ast 		abnormal coat/hair pigmentation J:73316
abnormal hair follicle melanocyte morphology J:73316
abnormal lymphocyte physiology J:73316
absent hair follicle melanin granules J:73316
diluted coat color J:73316
normal hearing/vestibular/ear phenotype J:73316
increased T cell apoptosis J:73316
normal mortality/aging J:73316
normal renal/urinary system phenotype J:73316
\Bcl2tm1Dlo/\Bcl2tm1Dlo
\Bcl2l11tm1.1Ast/\Bcl2l11+
B6.Cg-Bcl2tm1Dlo Bcl2l11tm1.1Ast 		increased leukocyte cell number J:153846
increased spleen weight J:153846
\Bcl2tm1Dlo/\Bcl2tm1Dlo
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
B6.129-Bcl2tm1Dlo Bcl2l11tm1.1Ast 		abnormal leukopoiesis J:73316
abnormal lymphocyte physiology J:73316
decreased B cell apoptosis J:73316
normal hearing/vestibular/ear phenotype J:73316
increased T cell apoptosis J:73316
normal integument phenotype J:73316
normal mortality/aging J:73316
normal renal/urinary system phenotype J:73316
\Bcl2tm1Dlo/\Bcl2tm1Dlo
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
B6.Cg-Bcl2tm1Dlo Bcl2l11tm1.1Ast 		increased leukocyte cell number J:153846
increased spleen weight J:153846
\Bcl2tm1Dlo/\Bcl2tm1Dlo
\Bcl2l11tm1.1Boui/\Bcl2l11tm1.1Boui
B6.Cg-Bcl2tm1Dlo Bcl2l11tm1.1Boui 		diluted coat color J:153846
normal growth/size/body region phenotype J:153846
normal hematopoietic system phenotype J:153846
normal immune system phenotype J:153846
normal renal/urinary system phenotype J:153846
\Bcl2tm1Dlo/\Bcl2tm1Dlo
\Bcl2l11tm1.1Boui/\Bcl2l11tm2.1Boui
B6.Cg-Bcl2tm1Dlo Bcl2l11tm1.1Boui/Bcl2l11tm2.1Boui 		normal hematopoietic system phenotype J:153846
normal immune system phenotype J:153846
increased leukocyte cell number J:153846
increased spleen weight J:153846
normal renal/urinary system phenotype J:153846
\Bcl2tm1Dlo/\Bcl2tm1Dlo
\Bcl2l11tm2.1Boui/\Bcl2l11tm2.1Boui
B6.Cg-Bcl2tm1Dlo Bcl2l11tm2.1Boui 		diluted coat color J:153846
normal growth/size/body region phenotype J:153846
normal hematopoietic system phenotype J:153846
normal immune system phenotype J:153846
normal renal/urinary system phenotype J:153846
\Bcl2tm1Dlo/\Bcl2tm1Dlo
\Bcl2l11tm3.1Boui/\Bcl2l11tm3.1Boui
B6.Cg-Bcl2tm1Dlo Bcl2l11tm3.1Boui 		decreased splenocyte apoptosis J:153846
normal hematopoietic system phenotype J:153846
normal immune system phenotype J:153846
increased leukocyte cell number J:153846
increased spleen weight J:153846
polycystic kidney J:153846
postnatal growth retardation J:153846
premature death J:153846
\Bcl2l11em1Flv/\Bcl2l11+
\Morrbidem1Flv/\Morrbid+
C57BL/6N-Bcl2l11em1Flv Morrbidem1Flv /+ + 		normal immune system phenotype J:236609
\Bcl2l11em1Flv/\Bcl2l11+
\Morrbid+/\Morrbidem1Flv
C57BL/6N-Bcl2l11em1Flv +/+ Morrbidem1Flv 		decreased eosinophil cell number J:236609
decreased Ly6C high monocyte number J:236609
decreased neutrophil cell number J:236609
\Bcl2l11tm1.1Ast/\Bcl2l11+
\Ptentm1Hwu/\Pten+
\Tg(CD2-icre)4Kio/0
involves: 129S1/Sv * 129S4/SvJae * C57BL/10 * CBA/Ca 		abnormal T cell number J:133215
increased germinal center B cell number J:133215
\Bcl2l11tm1.1Ast/\Bcl2l11+
\Bmftm1Rjd/\Bmf+
B6.129S-Bcl2l11tm1.1Ast Bmftm1Rjd 		decreased body weight J:153652
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Biktm1Ast/\Biktm1Ast
B6.Cg-Bcl2l11tm1.1Ast Biktm1Ast 		abnormal B cell differentiation J:103605
abnormal lymphocyte physiology J:103605
abnormal seminiferous tubule morphology J:103605
abnormal spermatogenesis J:103605
abnormal T cell differentiation J:103605
arrest of male meiosis J:103605
azoospermia J:103605
decreased body weight J:103605
decreased immature B cell number J:103605
decreased pre-B cell number J:103605
decreased pro-B cell number J:103605
decreased testis weight J:103605
enlarged spleen J:103605
increased B cell number J:103605
increased granulocyte number J:103605
increased mature B cell number J:103605
increased monocyte cell number J:103605
increased T cell number J:103605
male infertility J:103605
multinucleated giant male germ cells J:103605
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Bmftm1Rjd/\Bmftm1Rjd
B6.129S-Bcl2l11tm1.1Ast Bmftm1Rjd 		decreased body weight J:153652
decreased T cell apoptosis J:153652
hydrometrocolpos J:153652
increased B cell number J:153652
increased CD4-positive, alpha-beta T cell number J:153652
increased CD8-positive, alpha-beta T cell number J:153652
increased splenocyte number J:153652
increased thymocyte number J:153652
interdigital webbing J:153652
postnatal lethality, incomplete penetrance J:153652
vagina atresia J:153652
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Bmftm2.1Rjd/\Bmftm2.1Rjd
B6.129S-Bcl2l11tm1.1Ast Bmftm2.1Rjd 		increased B cell number J:153652
increased CD4-positive, alpha-beta T cell number J:153652
increased CD8-positive, alpha-beta T cell number J:153652
increased splenocyte number J:153652
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Bnip3lGt(XT0573)Wtsi/\Bnip3lGt(XT0573)Wtsi
involves: 129S1/Sv * C57BL/6 		decreased erythrocyte cell number J:137609
decreased lymphocyte cell number J:137609
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Dicer1tm1Mmk/\Dicer1tm1Mmk
\Cd79atm1(cre)Reth/\Cd79a+
involves: 129S1/Sv * BALB/c 		decreased B cell number J:135783
decreased mature B cell number J:135783
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Faslpr/\Faslpr
B6.Cg-Bcl2l11tm1.1Ast Faslpr 		abnormal effector T cell morphology J:132217
abnormal glomerular capillary morphology J:132217
abnormal kidney morphology J:132217
abnormal lymph node cell ratio J:132217
abnormal renal glomerulus basement membrane morphology J:132217
abnormal renal glomerulus morphology J:132217
abnormal splenic cell ratio J:132217
abnormal T cell number J:132217
abnormal T cell subpopulation ratio J:132217
decreased B cell number J:132217
decreased spleen red pulp amount J:132217
enlarged lymph nodes J:132217
enlarged spleen J:132217
expanded mesangial matrix J:132217
increased anti-double stranded DNA antibody level J:132217
increased anti-histone antibody level J:132217
increased anti-nuclear antigen antibody level J:132217
increased anti-single stranded DNA antibody level J:132217
increased autoantibody level J:132217
increased dendritic cell number J:132217
increased follicular B cell number J:132217
increased immature B cell number J:132217
increased kidney cell proliferation J:132217
increased leukocyte cell number J:132217
increased macrophage cell number J:132217
increased marginal zone B cell number J:132217
increased memory T cell number J:132217
increased renal glomerulus apoptosis J:132217
increased renal glomerulus basement membrane thickness J:132217
increased spleen white pulp amount J:132217
increased susceptibility to autoimmune disorder J:132217
increased transitional stage B cell number J:132217
lymph node hyperplasia J:132217
renal glomerulus hypertrophy J:132217
spleen hyperplasia J:132217
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Gata1tm1.1Yen/\Gata1tm1.1Yen
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N 		decreased erythroid progenitor cell number J:200716
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Il15tm1Imx/\Il15tm1Imx
involves: C57BL/6 		normal immune system phenotype J:208318
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Mirc14tm1.2Flv/\Mirc14tm1.2Flv
involves: 129S1/Sv * C57BL/6 * C57BL/6N * FVB/N * SJL 		decreased NK T cell number J:203157
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Mlf1tm1Swm/\Mlf1tm1Swm
involves: 129S1/Sv * C57BL/6 		decreased splenocyte apoptosis J:266833
decreased thymocyte apoptosis J:266833
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Pmaip1tm1Ast/\Pmaip1tm1Ast
involves: 129S1/Sv * C57BL/6 		abnormal NK cell morphology J:123409
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Zbtb1m1Btlr/\Zbtb1m1Btlr
involves: 129S1/Sv * C3H/HeN * C57BL/6 * C57BL/6J 		absent T cells J:178820
\Bcl2l11tm1.1Boui/\Bcl2l11+
\Tg(IghMyc)22Bri/0
involves: C57BL/6 * SJL 		increased B cell derived lymphoma incidence J:186117
increased leukocyte cell number J:186117
increased T cell derived lymphoma incidence J:186117
premature death J:186117
\Bcl2l11tm1.1Boui/\Bcl2l11tm1.1Boui
\Tg(IghMyc)22Bri/0
involves: C57BL/6 * SJL 		increased B cell derived lymphoma incidence J:186117
increased leukocyte cell number J:186117
premature death J:186117
\Bcl2l11tm1Ast/\Bcl2l11tm1Ast
\Dicer1tm1Bdh/\Dicer1tm1Bdh
\Aicdatm1(cre)Njen/\Aicda+
involves: 129S1/Sv * C57BL/6 		abnormal B cell differentiation J:181782
decreased germinal center B cell number J:181782
decreased plasma cell number J:181782
\Bcl2l11tm2.1Boui/\Bcl2l11+
\Tg(IghMyc)22Bri/0
involves: C57BL/6 * SJL 		increased B cell derived lymphoma incidence J:186117
increased leukocyte cell number J:186117
premature death J:186117
\Bcl2l11tm2.1Boui/\Bcl2l11tm2.1Boui
\Tg(IghMyc)22Bri/0
involves: C57BL/6 * SJL 		increased B cell derived lymphoma incidence J:186117
increased leukocyte cell number J:186117
premature death J:186117
\Bcl2l11tm3.1Boui/\Bcl2l11+
\Tg(IghMyc)22Bri/0
involves: C57BL/6 * SJL 		increased B cell derived lymphoma incidence J:186117
premature death J:186117
\Bcl2l11tm3.1Boui/\Bcl2l11tm3.1Boui
\Tg(IghMyc)22Bri/0
involves: C57BL/6 * SJL 		increased B cell derived lymphoma incidence J:186117
premature death J:186117
\Bcl2l11tm3Rjd/\Bcl2l11tm3Rjd
\Bmftm3.1Rjd/\Bmftm3.1Rjd
B6.129S6-Bcl2l11tm3Rjd Bmftm3.1Rjd 		increased B cell number J:153652
increased CD4-positive, alpha-beta T cell number J:153652
increased CD8-positive, alpha-beta T cell number J:153652
increased splenocyte number J:153652
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
03/25/2025
MGI 6.24 		The Jackson Laboratory